BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 24635793)

  • 21. Successful treatment of donor-derived hepatitis C viral infection in three transplant recipients from a donor at increased risk for bloodborne pathogens.
    Shah AP; Cameron A; Singh P; Frank AM; Fenkel JM
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28060446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognosis of Patients Following Liver Transplant From Deceased and Living Donors.
    Yesmembetov K; Sultanaliyev T; Mukazhanov A; Zhexembayev A; Kuttymuratov G; Spatayev Z; Mussin Y; Umbetzhanov Y; Orazbayeva D
    Exp Clin Transplant; 2018 Mar; 16 Suppl 1(Suppl 1):152-153. PubMed ID: 29528015
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increasing nonalcoholic steatohepatitis overlap in liver transplant recipients: Additive risk for de novo malignancy.
    Nasser-Ghodsi N; Mara K; Allen AM; Watt KD
    Clin Transplant; 2022 Aug; 36(8):e14714. PubMed ID: 35594161
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of Liver Offers to Pediatric Candidates on the Transplant Wait List.
    Hsu EK; Shaffer ML; Gao L; Sonnenday C; Volk ML; Bucuvalas J; Lai JC
    Gastroenterology; 2017 Oct; 153(4):988-995. PubMed ID: 28711630
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Donor-derived Viral Infections in Liver Transplantation.
    Nam H; Nilles KM; Levitsky J; Ison MG
    Transplantation; 2018 Nov; 102(11):1824-1836. PubMed ID: 29979345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review.
    Chak E; Saab S
    Liver Int; 2010 Oct; 30(9):1247-58. PubMed ID: 20602682
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of center volume on outcomes of increased-risk liver transplants.
    Ozhathil DK; Li YF; Smith JK; Tseng JF; Saidi RF; Bozorgzadeh A; Shah SA
    Liver Transpl; 2011 Oct; 17(10):1191-9. PubMed ID: 21604357
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Liver transplant recipients are not at increased risk for nonlymphoid solid organ tumors.
    Kelly DM; Emre S; Guy SR; Miller CM; Schwartz ME; Sheiner PA
    Cancer; 1998 Sep; 83(6):1237-43. PubMed ID: 9740091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gender Matches in Liver Transplant Allocation: Matched and Mismatched Male-Female Donor-Recipient Combinations; Long-term Follow-up of More Than 2000 Patients at a Single Center.
    Schoening WN; Helbig M; Buescher N; Andreou A; Bahra M; Schmitz V; Pascher A; Pratschke J; Seehofer D
    Exp Clin Transplant; 2016 Apr; 14(2):184-90. PubMed ID: 27015533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Results of liver transplants from donors aged 70 plus: analysis of Andalusian transplant register.
    Franco CC; Martínez JM; Bellido CB; Artacho GS; Gómez LM; Diez-Canedo JS; Aunión CD; Ruiz FJ; Bravo MA
    Transplant Proc; 2013; 45(10):3647-9. PubMed ID: 24314984
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nationwide population-based study reveals increased malignancy risk in taiwanese liver transplant recipients.
    Tsai YF; Chen HP; Liu FC; Liu SH; Chen CY; Cheng CW; Lin JR
    Oncotarget; 2016 Dec; 7(50):83784-83794. PubMed ID: 27626495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term care of transplant recipients: de novo neoplasms after liver transplantation.
    Burra P; Shalaby S; Zanetto A
    Curr Opin Organ Transplant; 2018 Apr; 23(2):187-195. PubMed ID: 29324517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
    Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
    Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recipient But Not Donor Adiponectin Polymorphisms Are Associated With Early Posttransplant Hepatic Steatosis in Patients Transplanted for Non-Nonalcoholic Fatty Liver Disease Indications.
    John BV; Aiken T; Garber A; Thomas D; Lopez R; Patil D; Konjeti VR; Fung JJ; McCollough AJ; Askar M
    Exp Clin Transplant; 2018 Aug; 16(4):439-445. PubMed ID: 29863454
    [TBL] [Abstract][Full Text] [Related]  

  • 35. De novo malignancies after kidney and liver transplantations: experience on 582 consecutive cases.
    Baccarani U; Adani GL; Montanaro D; Risaliti A; Lorenzin D; Avellini C; Tulissi P; Groppuzzo M; Currò G; Luvisetto F; Beltrami A; Bresadola V; Viale PL; Bresadola F
    Transplant Proc; 2006 May; 38(4):1135-7. PubMed ID: 16757287
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Primary cytomegalovirus infection in liver transplant recipients: comparison of infections transmitted via donor organs and via transfusions. Boston Center for Liver Transplantation CMVIG Study Group.
    Falagas ME; Snydman DR; Ruthazer R; Griffith J; Werner BG
    Clin Infect Dis; 1996 Aug; 23(2):292-7. PubMed ID: 8842266
    [TBL] [Abstract][Full Text] [Related]  

  • 37. De novo malignancies after liver transplantation: a major cause of late death.
    Fung JJ; Jain A; Kwak EJ; Kusne S; Dvorchik I; Eghtesad B
    Liver Transpl; 2001 Nov; 7(11 Suppl 1):S109-18. PubMed ID: 11689783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Defining long-term outcomes with living donor liver transplantation in North America.
    Olthoff KM; Smith AR; Abecassis M; Baker T; Emond JC; Berg CL; Beil CA; Burton JR; Fisher RA; Freise CE; Gillespie BW; Grant DR; Humar A; Kam I; Merion RM; Pomfret EA; Samstein B; Shaked A
    Ann Surg; 2015 Sep; 262(3):465-75; discussion 473-5. PubMed ID: 26258315
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liver transplantation using organs from deceased organ donors: a single organ transplant center experience.
    Han M; Guo ZY; Zhao Q; Wang XP; Yuan XP; Jiao XY; Yang CH; Wang DP; Ju WQ; Wu LW; Hu AB; Tai Q; Ma Y; Zhu XF; He XS
    Hepatobiliary Pancreat Dis Int; 2014 Aug; 13(4):409-15. PubMed ID: 25100126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Implications of Treating Hepatitis C Virus Infection Among Patients Awaiting Cadaveric Liver Transplant: A Single-Center Experience.
    Ofosu A; Durand CM; Saberi B; Alqahtani S; Ucbilek E; Belden M; Cameron AM; Gurakar A
    Exp Clin Transplant; 2015 Nov; 13 Suppl 3():7-10. PubMed ID: 26640901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.